RBC Capital Assumes Sarepta Therapeutics (SRPT) at Outperform
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $18.95 -7.65%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
RBC Capital assumes coverage on Sarepta Therapeutics (NASDAQ: SRPT) with a Outperform rating and a price target of $80.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutics click here. For more ratings news on Sarepta Therapeutics click here.
Shares of Sarepta Therapeutics closed at $62.38 Friday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Sarepta Therapeutics (SRPT) to Outperform
- Nomura/Instinet Starts Yuanjie Semiconductor Technology (688498:CH) at Neutral
- DA Davidson Starts AGCO Corporation (AGCO) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
